Relapsed/refractory diffuse large B-cell lymphoma: on the threshold of new therapies.
Sud
Rohit
R
Department of Medicine, University of Rochester, Rochester, New York, USA.
Friedberg
Jonathan W
JW
D003131:Combined Modality Therapy; D019008:Drug Resistance, Neoplasm; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy*